Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial - 14/12/18
, Rafael Marques Soares a, Lucas Petri Damiani a, Viviane Bezerra Campos a, Bruna Sampaio a, Juliana Yamashita a, Francisco H. Fonseca b, Maria Cristina Izar b, Celso Amodeo c, Octavio Marques Pontes-Neto d, Pedro Gabriel de Melo Barros a, e, Renato D. Lopes e, f, Nilton Brandão da Silva g, Hélio Penna Guimarães a, Leopoldo Piegas h, Airton T. Stein g, Otavio Berwanger aAbstract |
Background |
Translating evidence into clinical practice in the management of high cardiovascular risk patients is challenging. Few quality improvement interventions have rigorously evaluated their impact on both patient care and clinical outcomes.
Objectives |
The main objectives are to evaluate the impact of a multifaceted educational intervention on adherence to local guidelines for the prescription of statins, antiplatelets and angiotensin converting enzyme inhibitors or angiotensin II receptor blockers for high cardiovascular risk patients, as well as on the incidence of major cardiovascular events.
Design |
We designed a pragmatic two arm cluster randomized trial involving 40 clusters. Clusters are randomized to receive a multifaceted quality improvement intervention or to routine practice (control). The multifaceted intervention includes: reminders, care algorithms, training of a case manager, audit and feedback reports, and distribution of educational materials to health care providers. The primary endpoint is the adherence to combined evidence-based therapies (statins, antiplatelet therapy and angiotensin converting enzyme inhibitors or angiotensin receptor blockers) at 12 months after the intervention period in patients without contra-indications for these medications. All analyses follow the intention-to-treat principle and take the cluster design into account using linear mixed logistic regression modeling.
Summary |
If proven effective, this multifaceted intervention would have wide utility as a means of promoting optimal usage of evidence-based interventions for the management of high cardiovascular risk patients.
Le texte complet de cet article est disponible en PDF.Plan
| Hector O. Ventura, MD served as guest editor for this article. |
Vol 207
P. 40-48 - janvier 2019 Retour au numéro
Article précédent
- Rationale and design of the randomized prospective ATLAS study: void ransvenous eads in ppropriate ubjects
- Blandine Mondésert, Jamil Bashir, François Philippon, Marc Dubuc, Guy Amit, Derek Exner, Jacqueline Joza, David H. Birnie, Chris Lane, Bernice Tsang, Victoria Korley, Danna Spears, Andrea Ling, Angie Djuric, Eugene Crystal, Tom Hruczkowski, Jean-François Roux, Sandra Carroll, Vidal Essebag, Andrew D. Krahn, Jeff S. Healey
- An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial
- Maria Julia Machline-Carrion, Eliana Vieira Santucci, Lucas Petri Damiani, Cecilia Bahit, Germán Málaga, Octávio Marques Pontes-Neto, Sheila Cristina Ouriques Martins, Viviane Flumignan Zétola, Karina Normilio-Silva, Gabriel Rodrigues de Freitas, Alessandra Gorgulho, Antônio De Salles, Beatriz Gonzales Pacheco da Silva, Juliana Yamashita Santos, Isabella de Andrade Jesuíno, Priscila Regina Torres Bueno, Alexandre Biasi Cavalcanti, Hélio Penna Guimarães, Ying Xian, Janet Prvu Bettger, Renato D. Lopes, Eric D. Peterson, Otávio Berwanger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?